Patents Assigned to E.P.O.S IASIS Research and Development Limited
  • Patent number: 11969473
    Abstract: The present invention provides compounds suitable for use in the treatment of conditions where it is beneficial to halt bone loss and kill cancer cells, particularly in metastases to and primary tumors in the bone and surrounding tissues. Consequently the present invention provides compounds comprising a bisphosphonate moiety linked to a phytochemical, pharmaceutical compositions thereof and methods of treatment of bone diseases and/or proliferative disorders.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: April 30, 2024
    Assignee: E.P.O.S IASIS Research and Development Limited
    Inventors: Andreani Odysseos, Andreas Evdokiou, Anastasios Keramidas
  • Patent number: 11400160
    Abstract: The present invention provides compounds suitable for use in the treatment of conditions where it is beneficial to halt bone loss and kill cancer cells, particularly in metastases to and primary tumours in the bone and surrounding tissues. Consequently the present invention provides compounds comprising a bisphosphonate moiety linked to a phytochemical, pharmaceutical compositions thereof and methods of treatment of bone diseases and/or proliferative disorders.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: August 2, 2022
    Assignee: E.P.O.S IASIS Research and Development Limited
    Inventors: Andreani Odysseos, Andreas Evdokiou, Anastasios Keramidas